Listen to Preston’s podcast about studying billionaires here: https://itunes.apple.com/us/podcast/the-investors-podcast/id928933489 Peter Thiel is an American venture capitalist, author, and entrepreneur with a net worth of $2.6 billion, according to Forbes. In 2014, he was included in the Forbes Midas List at No. 4. In 2017, he was featured on the Forbes 400 list. Thiel co-founded PayPal
0 Comments
Jeff Bezos, owner of Blue Origin, introduces a new lunar landing module called Blue Moon during an event at the Washington Convention Center, May 9, 2019 in Washington, DC. Mark Wilson | Getty Images The U.S. Government Accountability Office on Friday denied protests from companies affiliated with Jeff Bezos that NASA wrongly awarded a lucrative
0 Comments
Penn National (NASDAQ:PENN) has generated profits in each of the last two quarters — and the company’s first-quarter results were particularly impressive. But that’s not the only reason to like PENN stock. Source: Casimiro PT / Shutterstock.com On top of its quarterly performance, Penn National also looks critically well-positioned to benefit from a meaningful expansion
0 Comments
GameStop (NYSE:GME) stock has been one of 2021’s most incredible investing stories. The initial short squeeze was incredible to watch. Few market analysts could have ever imagined that a struggling mall retailer like GameStop could see its shares surge thousands of percent. Source: rblfmr / Shutterstock.com That surge, in turn, saved the company. GameStop raised
0 Comments
Other than a short-lived rally in June fueled by Reddit users, ContextLogic (NASDAQ:WISH) stock is on a permanent trajectory downward. Source: sdx15 / Shutterstock.com WISH stock peaked at $32.85, shortly after its initial public offering earlier this year. The company’s unfavorable valuations, mixed first-quarter results, and poor sales forecast continue to weigh on its share
0 Comments
Exchange-traded funds (ETFs) are giving mutual funds a run for investors’ money, and one reason is that ETFs can get around the tax hit that individual investors in mutual funds can encounter. Mutual fund investors pay capital gains tax on assets sold by their funds, with occasionally wrenching consequences. During the financial crisis, for example, many mutual funds were
0 Comments
Biotechnology company Cassava Sciences (NASDAQ:SAVA) has only two primary product candidates, but they’re highly significant. SAVA stock holders, like all biotech-sector investors, should stay informed on all clinical developments as they’re likely to influence the share price. Source: Shutterstock Cassava Sciences shares are particularly sensitive to news-related events. That’s not a bad thing, though, as the
0 Comments